fibrosarcoma (Cancer)
Information
- Disease name
- fibrosarcoma
- Disease ID
- DOID:3355
- Description
- "A connective tissue cancer that has_material_basis_in fibrous connective tissue and characterized by the presence of immature proliferating fibroblasts or undifferentiated anaplastic spindle cells in a storiform pattern." [url:http\://en.wikipedia.org/wiki/Fibrosarcoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02180867 | Active, not recruiting | Phase 2/Phase 3 | Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery | July 11, 2014 | December 22, 2024 |
| NCT00356031 | Completed | Phase 2 | Bevacizumab and Radiation Therapy for Sarcomas | July 2006 | March 2010 |
| NCT00400569 | Completed | Phase 2 | Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma | November 2006 | December 2011 |
| NCT00503295 | Completed | Phase 2 | Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung | June 2007 | April 2011 |
| NCT01962103 | Completed | Phase 1/Phase 2 | Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors | December 4, 2013 | November 6, 2018 |
| NCT02584309 | Completed | Phase 2 | Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma | February 22, 2016 | July 17, 2022 |
| NCT00141765 | Completed | Phase 2 | Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers | January 1997 | February 2010 |
| NCT06277154 | Not yet recruiting | Phase 2 | MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma | February 2024 | February 2027 |
| NCT06387485 | Recruiting | N/A | A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning | March 1, 2024 | April 1, 2025 |
| NCT03651375 | Unknown status | Phase 2 | Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall | February 11, 2017 | March 2022 |
| NCT03989596 | Unknown status | Phase 2 | Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas | June 1, 2018 | December 31, 2022 |
- Disase is a (Disease Ontology)
- DOID:201
- Cross Reference ID (Disease Ontology)
- GARD:2327
- Cross Reference ID (Disease Ontology)
- ICDO:8810/3
- Cross Reference ID (Disease Ontology)
- MESH:D005354
- Cross Reference ID (Disease Ontology)
- MESH:D018218
- Cross Reference ID (Disease Ontology)
- NCI:C3043
- Cross Reference ID (Disease Ontology)
- NCI:C6605
- Cross Reference ID (Disease Ontology)
- NCI:C7075
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:443250000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0016057
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0206643
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1336021
- Exact Synonym (Disease Ontology)
- Fibrocytic tumor
- Exact Synonym (Disease Ontology)
- fibrosarcoma of soft tissue
- Exact Synonym (Disease Ontology)
- fibrous tissue neoplasm
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100244
- MeSH unique ID (MeSH (Medical Subject Headings))
- D005354